We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Calls for New Psychosis Warnings on ADHD Drugs
FDA Calls for New Psychosis Warnings on ADHD Drugs
March 17, 2006
FDA officials are calling for new warnings about the possible risks of psychosis or mania associated with drugs that treat attention deficit/hyperactivity disorder (ADHD).